News

A class action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lily’s ...
A new class action lawsuit alleges that CVS Caremark unlawfully changed their coverage for popular GLP-1 drug Zepbound. | A ...
CVS Caremark is facing multiple federal lawsuits by patients challenging its decision to remove weight-loss drug Zepbound ...
A class action lawsuit has been filed against CVS Caremark (NYSE:CVS), the pharmacy benefit manager for health insurer Aetna, ...
CVS Caremark was sued Wednesday by two health plan participants who say the pharmacy benefit manager wrongly refuses to cover ...
Two New York residents have filed a lawsuit against CVS after the company’s pharmacy benefit manager, Caremark, denied ...
Increasing evidence shows the benefits of Wegovy and Zepbound, but too often insurers are the ones deciding who gets them.
In 2014, Caremark was accused of manipulating how drug costs were reported, prompting Aetna and SilverScript to submit false ...
Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the federal False Claims Act.
A Delaware judge ordered Caremark Rx Inc. to delay a shareholder vote on a proposed acquisition by CVS Corp. just hours after the drugstore operator heated up the bidding Tuesday by tripling the ...